Literature DB >> 25868682

[Psychoeducational Smoking Cessation Groups in an Acute Psychiatry Ward].

Gernot Fugger1, Rebekka Jung, Martin Aigner.   

Abstract

BACKGROUND: In view of the high prevalence of dependent smokers in psychiatric inpatient facilities advice for smoking cessation seems crucial. Due to the relatively short duration of stay in acute psychiatric wards (in our facility < 2 weeks) there is a need for therapeutic concepts that link to outpatient settings. The transtheoretical model by "Prochaska and DiClemente" (TTM) seems suitable to create an appropriate therapeutic concept.
METHODS: At the department of adult psychiatry located at Tulln university hospital, Austria, psychoeducational groups for smoking cessation were conducted. Apart from the degree of dependence using Fagerström test for nicotine-dependence (FTND), 100 mm visual analogue scales (VAS) were utilized to evaluate the patients' motivation for quitting smoking (100 VAS: maximimum motivation), the presenting physician (100 VAS: best performance), the content (100 VAS: best content) and the comprehensibility (100 VAS: optimum understanding).
RESULTS: Out of 37 participants, the majority (89.2 %), showed a moderate to very strong nicotine dependence. The median motivation for smoking cessation was 56 VAS, the median change in motivation 67 VAS, the content 96 VAS, comprehensibility 94 VAS and presenter was rated with 95 VAS.
CONCLUSIONS: In general, patients showed high levels of nicotine dependence. The psychoeducational group was predominantly evaluated in a positive way. Individual change in motivation to quit smoking might correspond to a stage in the TTM making a collaboration with outpatient facilities inevitable.

Entities:  

Mesh:

Year:  2015        PMID: 25868682     DOI: 10.1007/s40211-015-0143-0

Source DB:  PubMed          Journal:  Neuropsychiatr        ISSN: 0948-6259


  18 in total

1.  The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change.

Authors:  C C DiClemente; J O Prochaska; S K Fairhurst; W F Velicer; M M Velasquez; J S Rossi
Journal:  J Consult Clin Psychol       Date:  1991-04

2.  Predictive value of the transtheoretical model to smoking cessation in hospitalized patients with cardiovascular disease.

Authors:  Maud-Christine Chouinard; Sylvie Robichaud-Ekstrand
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2007-02

Review 3.  Nicotine use in schizophrenia: the self medication hypotheses.

Authors:  Veena Kumari; Peggy Postma
Journal:  Neurosci Biobehav Rev       Date:  2005       Impact factor: 8.989

4.  Reliability of the Fagerstrom Tolerance Questionnaire and the Fagerstrom Test for Nicotine Dependence.

Authors:  C S Pomerleau; S M Carton; M L Lutzke; K A Flessland; O F Pomerleau
Journal:  Addict Behav       Date:  1994 Jan-Feb       Impact factor: 3.913

5.  Treatment of nicotine dependence in the chronic mentally ill.

Authors:  C Rosen-Chase; V Dyson
Journal:  J Subst Abuse Treat       Date:  1999-06

Review 6.  Nicotine addiction.

Authors:  Neal L Benowitz
Journal:  N Engl J Med       Date:  2010-06-17       Impact factor: 91.245

7.  The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses.

Authors:  Stefan G Hofmann; Anu Asnaani; Imke J J Vonk; Alice T Sawyer; Angela Fang
Journal:  Cognit Ther Res       Date:  2012-07-31

Review 8.  Smoking cessation interventions for hospitalized smokers: a systematic review.

Authors:  Nancy A Rigotti; Marcus R Munafo; Lindsay F Stead
Journal:  Arch Intern Med       Date:  2008-10-13

Review 9.  Smoking cessation approaches for persons with mental illness or addictive disorders.

Authors:  Nady El-Guebaly; Janice Cathcart; Shawn Currie; Diane Brown; Susan Gloster
Journal:  Psychiatr Serv       Date:  2002-09       Impact factor: 3.084

Review 10.  Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis.

Authors:  Edward J Mills; Ping Wu; Ian Lockhart; Kristian Thorlund; Milo Puhan; Jon O Ebbert
Journal:  Ann Med       Date:  2012-08-06       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.